Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 護理學系所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23482
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor賴裕和(Yeur-Hur Lai)
dc.contributor.authorYu-Chen Chaoen
dc.contributor.author趙佑宸zh_TW
dc.date.accessioned2021-06-08T05:02:16Z-
dc.date.copyright2010-09-13
dc.date.issued2010
dc.date.submitted2010-08-20
dc.identifier.citation參考資料
中文部分
台北市政府衛生局(2002).許一個自在喜樂的休止符-談肺癌末期病患的積極安寧治療,取自11月15日,2009,http://www.taipei.gov.tw/cgi-bin/Message/MM_msg_control?mode=viewnews&ts=4635e38c:6ca2
行政院衛生署(2010).衛生統計系列(一)死因統計:98年度死因統計完整統計表,取自8月1日,2010,http://www.doh.gov.tw/CHT2006/DM/DM2_2_p02.aspx?class_no=440&now_fod_list_no=11122&level_no=3&doc_no=76512
何京鰲、王復維、杜明勳(2003).癌症病人之神經病變性疼痛.基層醫學,18(2),42-29。
余忠仁(2009).肺癌的防治.聲洋防癌之聲,(125),2-6。
何明霖(2005).肺癌流行病學•肺癌關懷團體網,取自11月19日,2009,http://www2.cch.org.tw/lungcancer/CR_PR_SD.htm
李梅琛、賴裕和、陳美伶、劉淑娟(2001).病人疼痛特質與疼痛信念對手術後使用止痛藥物之影響.護理雜誌,48(1),49-58。
李淑貞、賴裕和、邱宗傑、陳怡樺(2004).癌痛病患疼痛控制信念、殘障信念、感覺特質及其相關性之探討.護理雜誌,21(4),329-338。
林佳靜(1998).癌症疼痛因應量表之發展與癌症疼痛因應行為之探討.護理研 究,6(5),405-416。
林佳靜、陳淑如、謝麗鳳(1997).疼痛護理.護理雜誌,44(1),37-47。
林昌誠(2005).臺灣地區癌症患者之疼痛控制.北市醫學雜誌,2(5),423-428。
邱泰源(1997).癌症末期疼痛的控制.台灣醫學,1(2),198-208。
姜紹青(2006).抗癌化學藥物治療原則簡介.腫瘤護理雜誌,6(1),1-8。
施穎銘、陳育民(2008).非小細胞肺癌的標靶治療.內科學誌,19(1),8-13。
施穎銘、陳育民(2009).非小細胞肺癌手術後輔助性化學治療.內科學誌,20(6),490-496。
胡文郁(1997).癌症末期病人的疼痛護理.台灣醫學,1(6),758-763。
徐昀耀、陳怡靜、蔡圭豐(2009).口服麩醯胺以預防化學治療引起的周邊神經病變.腫瘤護理雜誌,9(1),13-22。
徐昌鴻(2009).化學治療藥物所引起的神經病變.腫瘤護理雜誌,9(1),1-12。
高以信、李楊成(2007).臨床醫療之癌症疼痛控制.基層醫學,22(5),178-183。
陳育民、彭瑞鵬(2006).使用於非小細胞肺癌的標靶治療.中華民國癌症醫學會雜誌,22(3),1-34。
陸坤泰、張登試(2001).台灣的肺癌.台灣醫學會,取自11月17日,2009,http://fma.mc.ntu.edu.tw/oldweb/data/%AA%CD%C0%F9.html.
陳晉興(2004).認識肺癌系列一:病因及分期.健康世界,(225),79-82。
曾翠華、林佳靜(2008).癌症疼痛.護理雜誌,55(2),16-21。
楊志新(2008).晚期非小細胞肺癌的標靶治療.台灣醫學,12(1),22-26。
楊志新、鄭安理(1998).癌症化學治療之新藥.台灣醫學,2( 3 ),312-315。
葉坤輝、鄭安理(1998).癌症化學治療之適應症.台灣醫學,2 ( 3 ),305 -311。
劉會平(2004).肺癌診斷與治療.腫瘤護理雜誌,4(2),25-34。
蔡琇文、賴裕和、陳美伶、陳主智(2000).癌症疼痛生理感覺特質與疾病不確定感關係之探討.護理研究,8(1),59-70。
蔡婷芳(2008).肺癌病患接受化學治療引發周邊神經病變及其對情緒與睡眠品 質的影響.未發表的碩士論文,台北:國立台灣大學醫學院護理研究所。
蔡麗雲、顧乃平、張澤芸、賴裕和(2001).癌痛病患的焦慮、憂鬱及其相關因素之探討.新臺北護理期刊,3(1),23-33。
賴裕和(2000).癌症病人對疼痛及麻醉性止痛藥之信念-量表發展與現況探討.護理研究,8(5),557-567。

英文部分
Ahles, T.A., Blanchard, E.B. & Ruckdeschel, J.C. (1983). The multidimensional nature of cancer-related pain. Pain, 17(3), 88–277.
Bach, P. B., Niewoehner, D. E., & Black, W. C. (2003). Screening for lung cancer: The guidelines. Chest, 123(1), 83S-88S.
Caraceni, A., & Portenoy, R.K. (1999). An international survey of cancer pain characteristics and syndromes. Pain, 82, 263-274.
Edrington, J., Sun, A., Wong, C., Dodd, M., Padilla, G., Paul, S.& Miaskowski, C. (2009). Barriers to Pain Management in a Community Sample of Chinese American Patients with Cancer. Journal of Pain and Symptom Management , 37(4), 665-675.
Fainsinger, R. L., Nekolaichuk C. L. (2008). A 'TNM' classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer, 16(6), 547-555.
Fischer, D. J., Villines, D., Kim, Y. O., Epstein, J. B. & Wilkie, D. J. (2009, Aug 17). Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer. [Epub ahead of print]
Hjermstad, M.J., Fainsinger, R., & Kaasa, S. (European Palliative Care Research Collaborative, EPCRC) (2009). Assessment and classification of cancer pain. Current Opinion in Supportive and Palliative Care,3(1), 24-30.
Hsu, T. H., Lu, M. S., Tsou, T.S. & Lin, C. C.(2003). The relationship of pain, uncertainty, and hope in Taiwanese lung cancer patients. Journal of Pain and Symptom Management , 26(3), 835-842.
Huang, C. C., Liu, M. T., Pi, C. P., Chang, T. H., Wang, A. Y. & Huang, C. Y. (2005). Treatment results of chemotherapy and radiotherapy in limited-stage small cell lung cancer. Therapeutic Radiology and Oncology, 12(1). 27-37.
Jensen, M. P., Karoly, P., & Huger, R. (1987). The development and preliminary validation of an instrument to assess patients' attitudes toward pain. Journal of Psychosomatic Research, 31(3), 393-400.
Lai, Y. H. (2009, June). Pain related experiences in patients with advanced lung cancer in Taiwan. Paper presented in 8th Research Symposium, IASP, in Chicago, USA.
Lai, Y. H., Dalton, J. A ., Belyea, M., Chen, M. L., Tsai, L. Y., & Chen, S. C. (2003). Development and Testing of the Pain Opioid Analgesics Beliefs Scale in Taiwanese Cancer Patients. Journal of Pain and Symptom Management, 25(4), 376-385.
Lai, Y. H., Guo, S. L ., Keefe , F . J., Tsai, S. L., Chien, C. C., Sung, Y. C., & Chen, M. L. ( 2004). Effects of brief pain education on hospitalized cancer patients with moderate to severe pain. Support Care Cancer, 12, 645–652.
Lai, Y. H., Keefe, F. J., Sun, W. Z., Tsai, L.Y., Cheng, P. L., Chiou, J. F. & Wei, L. L. (2002). Relationship between pain-specific beliefs and adherence to analgesic regimens in Taiwanese cancer patients. Journal of Pain and Symptom Management, 24(4), 415-423.
Li, K. K., Harris, K., Hadi, S.& Chow, E. (2007). What Should be the Optimal Cut Points for Mild, Moderate, and Severe Pain? Journal of Palliative Medicine, 10(6), 1338-1346.
Lin, C. C. (2000). Barriers to the analgesic management of cancer pain: a comparison of attitudes of Taiwanese patients and their family caregivers. Pain, 88, 7-14.
Merskey, H., & Bohduck, N. (1994). Classification of chronic pain (2nd ed., pp. xi-xv). Seattle, WA: IASP.
Paul, S. M., Zelman, D. C., Smith, M., & Miaskowski, C. (2005). Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain, 113(12), 37-44.
Pujol, J. L., & Mohammad, C. (2007). Staging metastasis profile of non-small cell lung cancer: a new paradigm? Journal of Thoracic Oncology, 2(8), 679-681.
Rivera, M. P., Detterbeck, F., & Mehta, A. C. (2003). Diagnosis of lung cancer: The guidelines. Chest 123(1), 129S-136S.
Serlin, R. C., Mendoza, T.R., Nakamura, Y., Edwards, K. R. & Cleeland, C. S. (1995).When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain, 61, 277-284.
Spiro, S. G., Tanner, N. T., Silvestri, G. A., Janes, S. M., Lim, E., Vansteenkiste, J. F., & Pirker, R. (2010). Lung cancer: progress in diagnosis, staging and therapyresp. Respirology, 15, 44–50.
Tanaka, K., Akechi, T., Okuyama, T., Nishiwaki, Y. & Uchitomi, Y. (2002). Impact of dyspnea, pain and fatigue on daily life activities in ambulatory patients with advanced lung cancer. Journal of Pain and Symptom Management, 23(5), 417-423.
Utne, I., Miaskowski, C., Bjordal , K ., Paul, S. M., Gunnhild, J. & Rustøen, T. (2009). Differences in the Use of Pain Coping Strategies Between Oncology Inpatients with Mild vs. Moderate to Severe Pain. Journal of Pain and Symptom Management , 38(5), 717-726.
Vallerand, A.H. (1997). Measurement issues in the comprehensive assessment of cancer pain. Seminars in Oncology Nursing, 13(1), 16-24.
van den Beuken-van Everdingen, M. H. J., de Rijke, J. M., Kessels,A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007). Prevalence of pain in patients with cancer: A systematicreview of the past 40 years. Annals of Oncology,18(9), 1437-1449.
Visovsky, C., Collins, M., Abbott, L., Aschenbrenner, J., & Hart, C. (2007). Putting evidence into practice: evidence-based interventions for chemotherapy - induced peripheral neuropathy. Clinical Journal of Oncology Nursing, 11, 901-913.
Williams, D. A.,& Thron, B. E.(1989). An empirical assessment of pain belief, Pain, 36(3), 351-358.
Wong, P. C., Dodd, M. J., Miaskowski , C., Paul , S. M., Bank, K. A., & Shiba, G. H. ( 2006). Mucositis pain induced by radiation therapy: prevalence, severity, and use of self-care behaviors. Journal of Pain and Symptom management, 32(1), 27-37.
Woolf, C. J., & Mannion, R. J. (1999). Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet, 353(9168), 1959-1964.
Yoder, L. H. (2006). An overview of lung cancer symptom, pathophysiology, and treatment. Medsurg Nursing, 15(4), 231-235.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23482-
dc.description.abstract疼痛為侵襲性肺癌病患最具威脅的一種症狀,但國內肺癌相關疼痛研究極為缺乏,故本研究目的為探討侵襲性肺癌病患疼痛生理特質與對生活之干擾情形、疼痛信念與疼痛因應策略及疼痛處理困難情形、疾病治療特質與周邊神經病變性疼痛情形。本研究採用橫斷式研究設計,以立意取樣收錄診斷為第III~IV分期之肺癌病患,排除一個月內執行手術之病患,以區分手術後急性疼痛與癌症慢性疼痛之差別,收案地點於台北某醫學中心之腫瘤科及胸腔內科門診,使用結構式問卷進行資料收集,包括:「基本資料表」、「簡易疼痛量表」、「麥基爾簡短版疼痛量表」、「疼痛及麻醉性止痛藥信念量表-癌症版」、「簡易疼痛因應策略量表」、「疼痛處理困難量表」及「神經性疼痛量表」。本研究共收案80人,結果顯示侵襲性肺癌病患最痛之疼痛強度為5.9分(SD=2.0),平均疼痛強度為3.8分(SD=1.7),疼痛干擾則以情緒影響最大,其次為日常生活及行走能力。發現病患皆普遍存有負向的忍耐疼痛與麻醉性止痛藥信念,疼痛因應策略以非藥物行為來因應疼痛為主,多數病患選擇忍耐疼痛。此外,化學治療引發周邊神經病變性疼痛之發生率為30.6%,以表面疼痛、尖銳刺痛及敏感痛最為常見。本研究結果顯示目前國內肺癌病患之疼痛控制及疼痛信念仍有待加強,因此,未來發展改善疼痛之介入措施是必要的,將有助於提昇肺癌病患的生活品質。zh_TW
dc.description.abstractPain is one of the most significant issues faced by advanced lung cancer patients. However, few studies have explored the pain experiences in lung cancer patients. Therefore, the purposes of this study were to (1) explore the pain severity and pain interference in advanced lung cancer patients; (2) explore the pain beliefs and coping strategies of advanced lung cancer patients; (3) identify the prevalence of chemotherapy-induced peripheral neuropathic pain (CIPN) and the degree of CIPN in advanced lung cancer patients. A cross-sectional survey study was conducted at a medical center in Taipei. Eligible subjects were patients diagnosed with lung cancer, clinical stage III-IV. For study purposes, patients who had undergone one or more operations within the previous one-month period were excluded from questions designed to identifying the different characteristics of acute surgical pain and chronic cancer pain. Patients were assessed by using (1) background information form, (2) Brief Pain Inventory (BPI), (3) Short-Form McGill Pain Questionnaire (SF-MPQ), (4) Pain and Opioid Analgesics Beliefs Scale-Cancer Version (POABS-CA), (5) Brief Pain Coping Inventory (BPCI), (6) Pain barriers Questionnaire, (7) Neuropathic Pain Scale (NPS). A total of 80 lung cancer patients were recruited in this study. The major results showed that the average pain intensity was 3.8 (SD=1.7) and the worst pain intensity was 5.9 (SD=2.0). The most severe pain interference was on mood, general activity and walking ability. The results also found that most patients had pain endurance beliefs and negative effect beliefs about using opioid analgesics. Besides, the prevalence of chemotherapy-induced peripheral neuropathic pain (CIPN) was 30.6%, and “surface pain,” “sharp pain,” and “sensitive pain” were most described by patients. The results suggest that poor cancer pain management is still a major problem to influence advanced lung cancer patients' daily life. We, therefore, strongly recommend that further interventions be developed to decrease pain problems.en
dc.description.provenanceMade available in DSpace on 2021-06-08T05:02:16Z (GMT). No. of bitstreams: 1
ntu-99-R97426003-1.pdf: 1481893 bytes, checksum: 34c01cfcc37e0247ac6a31f09cabcb09 (MD5)
Previous issue date: 2010
en
dc.description.tableofcontents口試委員會審定書.................................ii
中文摘要................................................iii
英文摘要................................................iv
目錄....................................................vi
表目錄..................................................vii
圖目錄.................................................viii
第一章 緒論............................................1
第一節 研究動機與重要性................................1
第二節 研究目的........................................3
第二章 文獻查證........................................4
第一節 侵襲性肺癌及其治療..............................4
第二節 疼痛生理特質....................................7
第三節 疼痛信念與疼痛因應策略.........................10
第四節 疼痛干擾.......................................12
第三章 研究方法.......................................13
第一節 研究架構.......................................13
第二節 名詞解釋及操作型定義...........................14
第三節 研究設計.......................................15
第四節 研究對象及場所.................................16
第五節 研究工具.......................................17
第六節 資料收集.......................................20
第七節 資料處理及分析.................................21
第八節 研究倫理考量...................................22
第四章 研究結果.......................................23
第一節 病患基本資料分析...............................23
第二節 疼痛生理特質及嚴重度...........................29
第三節 疼痛信念與疼痛因應策略及疼痛處理困難情形.......33
第四節 化學治療引發周邊神經病變性疼痛情形.............41
第五節 疼痛干擾與疼痛生理特質、疼痛信念之相關性.......43
第五章 討論...........................................47
第一節 病患疼痛生理特質與嚴重.........................47
第二節 忍耐疼痛與麻醉性止痛藥負向信念.................50
第三節 疼痛因應策略及疼痛處理困難情形.................52
第四節 化學治療引發周邊神經病變性疼痛特質與嚴重度.....54
第五節 疼痛干擾與疼痛特質、疼痛信念、疼痛因應策略及疼痛處理困難之相關性...............................56
第六章 結論與建議.....................................58
第一節 結論...........................................58
第二節 研究限制與建議.................................59
第三節 護理上之應用...................................60
參考資料...............................................61
中文部分...............................................61
英文部分...............................................63
dc.language.isozh-TW
dc.title侵襲性肺癌病患之疼痛經驗探討zh_TW
dc.titlePain Experiences in Advanced Lung Cancer Patientsen
dc.typeThesis
dc.date.schoolyear98-2
dc.description.degree碩士
dc.contributor.oralexamcommittee楊志新(Chih-Hsin Yang),林至芃(Chih-Ping Lin)
dc.subject.keyword肺癌,疼痛,疼痛干擾,疼痛信念,疼痛因應,周邊神經病變性疼痛,zh_TW
dc.subject.keywordLung cancer,Pain,Pain interference,Pain brief,Pain coping,Peripheral neuropathic pain,en
dc.relation.page66
dc.rights.note未授權
dc.date.accepted2010-08-20
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept護理學研究所zh_TW
顯示於系所單位:護理學系所

文件中的檔案:
檔案 大小格式 
ntu-99-1.pdf
  目前未授權公開取用
1.45 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved